Terms: = Gastric cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Clinical Outcome
2 results:
1. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
[TBL] [Abstract] [Full Text] [Related]
2. Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer.
Buffart TE; Carvalho B; van Grieken NC; van Wieringen WN; Tijssen M; Kranenbarg EM; Verheul HM; Grabsch HI; Ylstra B; van de Velde CJ; Meijer GA
Oncologist; 2012; 17(5):653-62. PubMed ID: 22531355
[TBL] [Abstract] [Full Text] [Related]
